Apellis Pharmaceuticals (APLS) Stock Price
$17.3 0%
to add to portfolio
AI Score
-
Alternative
4 -
Fundamental
2 -
Technical
2
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Apellis Pharmaceuticals, AI stock picks, stock alerts and much more.
APLS AI Stock Analysis
AI stock analysis for APLS is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Apellis Pharmaceuticals (APLS) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Apellis Pharmaceuticals (APLS) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Apellis Pharmaceuticals (APLS), currently trading at $17.3, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About APLS
-
Apellis Pharmaceuticals, Inc.
-
Symbol
APLS
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
2.2B
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$23.37 2.7% |
6 |
 |
Inovio Pharmaceuticals INO |
$1.8 1.1% |
1 |
 |
Moderna MRNA |
$24.25 0.5% |
3 |
 |
Anavex Life Sciences AVXL |
$8.25 3.6% |
5 |
 |
BridgeBio Pharma BBIO |
$34.17 2% |
6 |
News
APLS Alternative Data
Web Traffic
Apellis Pharmaceuticals receives an estimated 33213 monthly visitors to apellis.com, which is down by -30.9% over the last month.
-
Web Traffic
33213
-
Change from Previous Month
30.9%
-
3 Month Change
69.2%
-
YoY Change
69.2%
Twitter Followers
Apellis Pharmaceuticals has 1,636 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.1% over the last month.
-
Twitter Followers
1636
-
Daily Change
0%
-
1 Month Change
0.1%
-
3 Month Change
0.1%
-
YoY Change
0.1%
Youtube Subscribers
Apellis Pharmaceuticals has 832 subscribers on its main Youtube channel, up by 0.1% over the last month.
-
Youtube Subscribers
832
-
Daily Change
0%
-
1 Month Change
0.1%
-
3 Month Change
0.1%
-
YoY Change
0.1%
LinkedIn Followers
81,362 are following Apellis Pharmaceuticals on LinkedIn, up by 1.7% over the last month.
-
LinkedIn Followers
81362
-
Daily Change
0%
-
1 Month Change
1.7%
-
3 Month Change
7.8%
Job Postings
Apellis Pharmaceuticals has an estimated 24 open job postings, which is down -46.7% over the last month.
-
Job Postings
24
-
Daily Change
0%
-
1 Month Change
46.7%
-
3 Month Change
48.9%
-
YoY Change
48.9%
LinkedIn Employees
According to LinkedIn, Apellis Pharmaceuticals has 757 employees.
-
LinkedIn Employees
757
-
Daily Change
0.1%
-
1 Month Change
0%
-
3 Month Change
0.8%
-
YoY Change
0.8%
Reddit Mentions
Apellis Pharmaceuticals has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
News Mentions
Apellis Pharmaceuticals was mentioned 4 times in the news yesterday.
-
News Mentions
4
-
Daily Change
33.3%
-
1 Month Change
0%
-
3 Month Change
0%
Business Outlook
According to employee reviews, the business outlook among employees at Apellis Pharmaceuticals is 42 out of 100 (neutral).
-
Business Outlook
42
-
Change from Previous Month
8.7%
-
3 Month Change
0%
-
YoY Change
0%
App Downloads
-
App Downloads
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
APLS Financials
APLS Key Metrics
-
Total Revenue
$212.5M
-
Net Income
-$36.4M
-
Earnings per Share
-$0.29
-
Free cash flow
$19.3M
-
EBITDA
-$24.1M
-
EBITDA Ratio
-0.113298
-
Total Assets
$885.1M
APLS 2-year Revenue & Income
APLS 2-year Free Cash Flow
APLS Technicals
APLS SMA
APLS RSI
FAQ
What's the current price of Apellis Pharmaceuticals (APLS) Stock?
The price of an Apellis Pharmaceuticals (APLS) share is $17.3.
What's the market cap of Apellis Pharmaceuticals?
The current market cap of Apellis Pharmaceuticals is 2.2B.
Should I buy or sell APLS?
Apellis Pharmaceuticals exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.
Is Apellis Pharmaceuticals a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Apellis Pharmaceuticals stock. There are several bearish signals and market challenges that could negatively impact Apellis Pharmaceuticals' future performance, suggesting that caution should be exercised before making any investment decisions.
Is now a good time to buy Apellis Pharmaceuticals (APLS) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Apellis Pharmaceuticals stock right now, as the outlook appears bearish.
What are some stocks similar to Apellis Pharmaceuticals (APLS) that investors often compare it to?
Apellis Pharmaceuticals (APLS) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Apellis Pharmaceuticals' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Apellis Pharmaceuticals' stock price to be around $16.07 in 2026. Starting from the current price of $17.3, this represents a 7.1% change in price, indicating a bearish outlook for the stock.
How to buy Apellis Pharmaceuticals (APLS) Stock?
Apellis Pharmaceuticals stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Apellis Pharmaceuticals shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.